[{"AccountsPayableCurrent_0_Q2_USD":60632000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":136738000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.04,"OtherAssetsNoncurrent_0_Q2_USD":163016000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1_Q2_USD":-610000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2_Q2_USD":2430000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_1_Q2_USD":168000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_2_Q2_USD":-671000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q2_USD":-30000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2_Q2_USD":-51000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_1_Q2_USD":8000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_2_Q2_USD":14000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":3653000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-6266000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":3000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":1000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":3073000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-3785000.0,"OperatingLeasePayments_2_Q2_USD":27470000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":126688000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":100826000.0,"OperatingLeaseCost_2_Q2_USD":25215000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2049980000.0,"LiabilitiesCurrent_0_Q2_USD":616297000.0,"LongTermDebtCurrent_0_Q2_USD":152500000.0,"LongTermDebtNoncurrent_0_Q2_USD":288343000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11233000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-55235000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1859000.0,"NetIncomeLoss_2_Q2_USD":106768000.0,"NetIncomeLoss_1_Q2_USD":59338000.0,"NonoperatingIncomeExpense_1_Q2_USD":-4012000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2430000.0,"NumberOfReportableSegments_2_Q2_Segment":10.0,"OperatingExpenses_1_Q2_USD":446704000.0,"OperatingExpenses_2_Q2_USD":890251000.0,"OperatingIncomeLoss_1_Q2_USD":85376000.0,"OperatingIncomeLoss_2_Q2_USD":148289000.0,"OperatingLeaseCost_1_Q2_USD":12400000.0,"OperatingLeaseLiability_0_Q2_USD":137856000.0,"Liabilities_0_Q2_USD":1132154000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":60410000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":18963000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":200000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":500000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q2_USD":6580000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_2_Q2_USD":13383000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":6405000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":5928000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":265400000.0,"SubleaseIncome_1_Q2_USD":1828000.0,"SubleaseIncome_2_Q2_USD":3812000.0,"TreasuryStockShares_0_Q2_shares":40400000.0,"TreasuryStockValue_0_Q2_USD":1509867000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":60410000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":10004000.0,"VariableLeaseCost_1_Q2_USD":1656000.0,"VariableLeaseCost_2_Q2_USD":3024000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":51557000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":51850000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":917826000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":38329000.0,"StockholdersEquity_0_Q2_USD":917826000.0,"ShortTermLeaseCost_1_Q2_USD":238000.0,"PaymentsToAcquireInvestments_2_Q2_USD":6973000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q2_USD":17476000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":36849000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":126586000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":130000000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":7550000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":474167000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":25000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":1909179000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":704055000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1381081000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":59000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":13729000.0,"SellingExpense_1_Q2_USD":277893000.0,"SellingExpense_2_Q2_USD":551639000.0,"ShareBasedCompensation_2_Q2_USD":13383000.0,"ShortTermInvestments_0_Q2_USD":24499000.0,"ShortTermLeaseCost_2_Q2_USD":577000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":50115000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":19479000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":24074000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":342541000.0,"DeferredTaxAssetsLiabilitiesNet_0_Q2_USD":27100000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":37925000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":19581000.0,"DerivativeNotionalAmount_0_Q2_USD":200000000.0,"DerivativeNumberOfInstrumentsHeld_0_Q2_Derivatives":4.0,"DividendsCommonStockCash_1_Q2_USD":19040000.0,"DividendsCommonStockCash_2_Q2_USD":38329000.0,"EarningsPerShareBasic_1_Q2_USD":1.18,"EarningsPerShareBasic_2_Q2_USD":2.12,"EarningsPerShareDiluted_1_Q2_USD":1.15,"EarningsPerShareDiluted_2_Q2_USD":2.06,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.271,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.268,"EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_2_Q2_USD":-5781000.0,"FinanceLeaseInterestExpense_1_Q2_USD":83000.0,"FinanceLeaseInterestExpense_2_Q2_USD":171000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":171975000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":173000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":-5600000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":23800000.0,"AccountsReceivableNetCurrent_0_Q2_USD":64701000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":403165000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-68553000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":586976000.0,"Assets_0_Q2_USD":2049980000.0,"AssetsCurrent_0_Q2_USD":961522000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":354759000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":354759000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-47924000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2_Q2_USD":97000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommonStockSharesIssued_0_Q2_shares":90600000.0,"CommonStockValue_0_Q2_USD":91000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":62411000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":102983000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":-4000000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":24079000.0,"FinanceLeaseLiability_0_Q2_USD":8498000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2230000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2789000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-55429000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-3007000.0,"IncreaseDecreaseInInventories_2_Q2_USD":80224000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":19897000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":5623000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":33061000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":98955000.0,"InventoryFinishedGoods_0_Q2_USD":218566000.0,"InventoryNet_0_Q2_USD":390977000.0,"InventoryRawMaterials_0_Q2_USD":172411000.0,"LeaseCost_1_Q2_USD":13155000.0,"LeaseCost_2_Q2_USD":26392000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":157335000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":34753000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":14237000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":18965000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4930000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":9220000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":39091000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":145859000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1436000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2035000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2148000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1109000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":722000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":956000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":606000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":1217000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.038,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":-2415000.0,"GainLossOnDispositionOfAssets_2_Q2_USD":-2189000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":168811000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":338612000.0,"Goodwill_0_Q2_USD":215582000.0,"GrossProfit_1_Q2_USD":532080000.0,"GrossProfit_2_Q2_USD":1038540000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":81364000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":22026000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":50409000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES, INC.","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20210805"}]